DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
+35.17%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$336M
AUM Growth
+$336M
(+9.2%)
Cap. Flow
-$49.4M
Cap. Flow
% of AUM
-14.71%
Top 10 Holdings %
Top 10 Hldgs %
56.86%
Holding
90
New
10
Increased
16
Reduced
26
Closed
16
Top Buys
| 1 |
Galapagos
GLPG
|
$3.56M |
| 2 |
Cassava Sciences
SAVA
|
$3.07M |
| 3 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$2.94M |
| 4 |
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
|
$2.71M |
| 5 |
Venus Concept
VERO
|
$2.6M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$22.2M |
| 2 |
Arcturus Therapeutics
ARCT
|
$9.85M |
| 3 |
Fate Therapeutics
FATE
|
$9.47M |
| 4 |
BEAT
BioTelemetry, Inc.
BEAT
|
$3.99M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$2.94M |
Sector Composition
| 1 | Healthcare | 89.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Stereotaxis
STXS
$261M
| $69.6M | 20.72% | 13,680,554 | – | – |
|
|
2
Fate Therapeutics
FATE
$120M
| $30.4M | 9.05% | 334,360 -104,100 | -24% | -$9.47M |
|
|
BPMC
3
DELISTED
Blueprint Medicines
BPMC
| $23.2M | 6.9% | 206,911 -26,178 | -11% | -$2.94M |
|
|
SAGE
4
DELISTED
Sage Therapeutics
SAGE
| $15.7M | 4.67% | 181,306 +23,000 | +15% | +$1.99M |
|
|
DRNA
5
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $12.9M | 3.85% | 587,756 +133,520 | +29% | +$2.94M |
|
6
Neurocrine Biosciences
NBIX
$13.8B
| $8.84M | 2.63% | 92,208 +2,000 | +2% | +$192K |
|
|
7
Galapagos
GLPG
$2.07B
| $7.96M | 2.37% | 80,375 +36,000 | +81% | +$3.56M |
|
8
DexCom
DXCM
$29.5B
| $7.82M | 2.33% | 21,138 | – | – |
|
9
AtriCure
ATRC
$1.84B
| $7.42M | 2.21% | 133,229 | – | – |
|
10
iShares Biotechnology ETF
IBB
$5.6B
| $7.18M | 2.14% | 47,400 -8,500 | -15% | -$1.29M |
|
|
BHVN
11
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $7.04M | 2.09% | 82,100 -2,500 | -3% | -$214K |
|
|
CSII
12
DELISTED
Cardiovascular Systems, Inc.
CSII
| $6.62M | 1.97% | 151,200 | – | – |
|
|
ARNA
13
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $5.9M | 1.76% | 76,815 +1,000 | +1% | +$76.8K |
|
14
Xenon Pharmaceuticals
XENE
$2.98B
| $5.33M | 1.59% | 346,535 | – | – |
|
15
ProQR Therapeutics
PRQR
$237M
| $5.2M | 1.55% | 1,237,400 | – | – |
|
|
AFMD
16
DELISTED
Affimed
AFMD
| $5.09M | 1.51% | 874,357 -49,921 | -5% | -$291K |
|
17
Neuronetics
STIM
$220M
| $4.93M | 1.47% | 443,717 -52,055 | -10% | -$578K |
|
18
IDEAYA Biosciences
IDYA
$2.15B
| $4.64M | 1.38% | 331,661 | – | – |
|
|
TBIO
19
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $4.15M | 1.24% | 225,393 +34,463 | +18% | +$635K |
|
20
Accuray
ARAY
$157M
| $4.06M | 1.21% | 974,400 -99,900 | -9% | -$417K |
|
|
TVRD
21
Tvardi Therapeutics, Inc. Common Stock
TVRD
$281M
| $3.96M | 1.18% | 261,442 +14,065 | +6% | +$213K |
|
|
AERI
22
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $3.9M | 1.16% | 288,440 +4,000 | +1% | +$54K |
|
23
Ascendis Pharma
ASND
$11.8B
| $3.88M | 1.15% | 23,237 -6,000 | -21% | -$1M |
|
|
AGTC
24
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $3.7M | 1.1% | 903,429 -191,710 | -18% | -$784K |
|
|
LMNX
25
DELISTED
Luminex Corp
LMNX
| $3.56M | 1.06% | 154,091 | – | – |
|